pan-TEAD-IN-1 (Compound 3) is an orally active pan- TEAD inhibitor targeting the palmitoylation site of TEAD , disrupting its interaction with the coactivators YAP/TAZ , thereby suppressing the transcriptional upregulation of oncogenes (e.g., Ctgf and Cyr61 ) in the Hippo signaling pathway. pan-TEAD-IN-1 exhibits excellent activity with a luciferase IC 50 of 0.36 nM and an H226 cell IC 50 of 1.52 nM. It also shows favorable pharmacokinetics (AUC 0–∞ = 228.7 μg/mL·min, T 1/2 = 183.9 min). In TEAD-dependent xenograft mouse models, pan-TEAD-IN-1 significantly inhibited tumor growth, showing promise for research in TEAD-dependent cancers.
Products | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Stem Cells | Products > Signaling Pathways > YAP
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.